Preliminary scientific tests reveal conolidine could inhibit specific ion channels, cutting down neuronal excitability and limiting soreness signals. This system is especially relevant in neuropathic agony, wherever irregular signaling results in persistent distress. On top of that, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to suffering https://georgesn590isn0.wikigop.com/user